Related Experiment Videos
Quantitative evaluation of sympathetic and parasympathetic control of iris function
Diabetes Care
|September 1, 1982
Summary
Pupil size measurements reliably assess autonomic nervous system (ANS) activity in both healthy and diabetic individuals. These methods accurately detect sympathetic nervous system (SNS) and parasympathetic nervous system (PNS) dysfunction in diabetes.
Area of Science:
- Ophthalmology
- Neurology
- Endocrinology
Background:
- The autonomic nervous system (ANS) regulates involuntary bodily functions, including pupillary response.
- Diabetes mellitus can lead to autonomic neuropathy, affecting nerve function.
- Quantitative pupillary measurements offer a non-invasive method to assess ANS function.
Purpose of the Study:
- To evaluate the utility of pupil size measurements as indicators of autonomic nervous system (ANS) activity.
- To assess sympathetic nervous system (SNS) and parasympathetic nervous system (PNS) function in diabetic subjects.
- To determine the reliability and sensitivity of pupillary indices in detecting autonomic dysfunction.
Main Methods:
- Measurement of steady-state pupil size before and after pharmacologic manipulation of ANS activity.
- Assessment of dark-adapted pupil size during complete parasympathetic blockade as an index of SNS activity.
- Evaluation of latency time (light stimulation to initial pupil response) as an index of PNS activity.
Main Results:
- Dark-adapted pupil size during PNS blockade reliably indicated SNS activity.
- Latency time served as a sensitive index for PNS activity, though influenced by SNS activity.
- Diabetic subjects exhibited impaired SNS and PNS activity, even in those without clinical neuropathy.
Conclusions:
- Quantitative pupillary measurements, specifically dark-adapted pupil size and latency time, are reliable and sensitive indices of SNS and PNS activity.
- These pupillary indices effectively detect autonomic dysfunction in diabetic individuals.
- The findings support the use of these methods for assessing autonomic neuropathy in diabetes.